Turn Therapeutics Inc. filed an updated corporate presentation for October 2026, containing forward-looking statements and risk disclosures typical for the company's business.
TURN news
Latest 3 stories ยท newest Oct 6, 2026
TURN
Turn Therapeutics Issues Investor Presentation for 2026
TURN
Turn Therapeutics updates stockholder presentation
Turn Therapeutics released an updated corporate presentation on July 28, 2026. The filing was submitted to the SEC and included forward-looking statements regarding the company's pipeline and commercial prospects.
TURN
Turn Therapeutics presents 2026 investor update at Jefferies Healthcare Conference
Turn Therapeutics presented an investor presentation at the Jefferies Global Healthcare Conference in June 2026. The presentation included forward-looking statements regarding the company's pipeline, including its PermaFusion product, with standard disclaimers about regulatory and commercial risks.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same TURN feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/TURN/newsSTART FREE